Unveiling a Glycation Hot Spot in a Recombinant Humanized Monoclonal Antibody

Biotechnological companies and regulatory agencies are pursuing the complete characterization of protein therapeutics in every detail as a means to mitigate risks of product quality related safety issues. During the characterization of a recombinant humanized monoclonal antibody (referred to as rhuM...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Analytical chemistry (Washington) 2008-01, Vol.80 (7), p.2379-2390
Hauptverfasser: Zhang, Boyan, Yang, Yi, Yuk, Inn, Pai, Roger, McKay, Patrick, Eigenbrot, Charles, Dennis, Mark, Katta, Viswanatham, Francissen, Kathleen Champion
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!